Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact. The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma.

Mr. Belson will address a variety of topics including: The significance of Real World Evidence for the pharmaceutical and medical device industry; and, how the FDA views Real World Evidence. 

This is the first podcast in a series.